Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.98 - $115.74 $208,055 - $243,285
2,102 Added 4.72%
46,602 $5.39 Million
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $273,701 - $319,271
2,841 Added 6.82%
44,500 $4.58 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $266,797 - $282,161
2,486 Added 6.35%
41,659 $4.55 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $334,036 - $609,285
5,354 Added 15.83%
39,173 $4.46 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $674,869 - $969,810
11,454 Added 51.21%
33,819 $2.09 Million
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $45,655 - $66,907
575 Added 2.64%
22,365 $1.78 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $1.19 Million - $1.51 Million
13,714 Added 169.81%
21,790 $2.29 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $120,341 - $146,410
1,221 Added 17.81%
8,076 $870,000
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $60,017 - $72,071
-653 Reduced 8.7%
6,855 $751,000
Q2 2021

Aug 16, 2021

SELL
$86.24 - $95.92 $3.56 Million - $3.96 Million
-41,325 Reduced 84.63%
7,508 $703,000
Q1 2021

May 17, 2021

BUY
$71.83 - $95.48 $2.05 Million - $2.73 Million
28,554 Added 140.81%
48,833 $4.5 Million
Q4 2020

Feb 16, 2021

BUY
$67.0 - $84.39 $1.36 Million - $1.71 Million
20,279 New
20,279 $1.48 Million
Q4 2019

Feb 14, 2020

SELL
$25.43 - $36.67 $1.78 Million - $2.56 Million
-69,852 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$23.0 - $27.97 $1.61 Million - $1.95 Million
69,852 New
69,852 $1.9 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.